Trevi Therapeutics
Clinical trials sponsored by Trevi Therapeutics, explained in plain language.
-
New pill tested to quiet unstoppable coughs
Symptom relief CompletedThis study tested whether a new, long-acting tablet called nalbuphine ER could safely reduce the number of coughs per day in people with a persistent cough that hasn't responded to other treatments. It involved 66 adults and compared the active drug to a placebo (a dummy pill) to…
Phase: PHASE2 • Sponsor: Trevi Therapeutics • Aim: Symptom relief
Last updated Apr 02, 2026 14:57 UTC
-
Scientists test drug mix safety in healthy volunteers
Knowledge-focused CompletedThis study aimed to understand how a new extended-release pain medication (NAL ER) interacts with two existing drugs for lung scarring (pirfenidone and nintedanib). It involved 132 healthy adult volunteers to measure drug levels in the body and check for safety when these medicat…
Phase: PHASE1 • Sponsor: Trevi Therapeutics • Aim: Knowledge-focused
Last updated Mar 25, 2026 14:08 UTC